Scientific Opinion on the safety and efficacy of manganese compounds (E5) as feed additives for all species: manganese chelate of amino acids, hydrate, based on a dossier submitted by Zinpro Animal Nutrition Inc. by EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
   EFSA Journal 2013;11(8):3324 
 
Suggested citation: EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), 
2013.  Scientific  Opinion  on  the  safety  and  efficacy  of  manganese  compounds  (E5)  as  feed  additives  for  all  species: 
manganese chelate of amino acids, hydrate, based on a dossier submitted by Zinpro Animal Nutrition Inc. EFSA Journal 
2013;11(8):3324, 28 pp. doi:10.2903/j.efsa.2013.3324 
Available online: www.efsa.europa.eu/efsajournal  
 
© European Food Safety Authority, 2013 
SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of manganese compounds (E5) 
as feed additives for all species: manganese chelate of amino acids, hydrate, 
based on a dossier submitted by Zinpro Animal Nutrition Inc.
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
This scientific output, published on 23 October 2014, replaces the earlier version published on 10 January 2014.
4 
ABSTRACT 
Manganese, an essential trace element, functions as an enzyme activator and is a constituent of several enzymes. 
Primary  signs  of  manganese  deficiency  are  impaired  growth,  skeletal  abnormalities,  depressed  reproductive 
function, ataxia of the newborn and faults in lipid and carbohydrate metabolism. Manganese chelate of amino 
acids, hydrate is considered a safe  source of manganese for all animal species/categories, provided that the 
current maximum total contents of manganese authorised in feed are respected. Dietary manganese does not 
appear to cause any adverse effects in consumers at usual intake levels; manganese intake resulting from the 
consumption  of  tissues  and  products  of  animal  origin  is  low  compared  with  the  intake  resulting  from  the 
consumption of food of plant origin. The use manganese chelate of amino acids, hydrate, does not result in 
higher manganese deposition in edible tissues and products than that resulting from commonly used inorganic 
sources. The use of the additive in animal nutrition is of no concern for the safety of consumers, provided that 
the current maximum total contents of manganese authorised in feed are respected. Handling the additive is a 
possible hazard to the respiratory tract and the health of users; in the absence of adequate data regarding irritancy 
to the skin and eyes and dermal sensitisation, the additive should be considered as a potential skin and eye 
irritant and, owing to its residual peptide component, as a skin/respiratory  sensitiser. The use of manganese 
chelate of amino acids, hydrate, in animal nutrition for all animal species is not of concern for the environment, 
provided that the current maximum total contents of manganese authorised in feed are respected. Manganese 
chelate of amino acids, hydrate, is an effective source of manganese for all animal species and categories. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from European Commission, the Panel on Additives and Products or Substances 
used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of 
manganese chelate of amino acids, hydrate when used as feed additive for all animal species. 
Manganese, an essential trace element, functions as an enzyme activator and is a constituent of several 
enzymes (e.g. glycosyl transferases, pyruvate carboxylase, manganese superoxide dismutase). Primary 
signs of manganese deficiency are impaired growth, skeletal abnormalities, depressed reproductive 
function, ataxia of the newborn and faults in lipid and carbohydrate metabolism. 
Manganese  chelate  of  amino  acids,  hydrate  is  considered  a  safe  additive  for  all  animal 
species/categories, provided that the current maximum total contents of manganese authorised in feed 
are respected, that is, 100 mg/kg complete feedingstuffs for fish and 150 mg/kg for other species. 
Dietary manganese does not appear to cause any adverse effects in consumers at usual intake levels. 
Manganese intake resulting from the consumption of tissues and products of animal origin is low 
compared with the intake resulting from the consumption of food of plant origin. The use manganese 
chelate of amino acids, hydrate, does not result in higher manganese deposition in edible tissues and 
products than that resulting from commonly used inorganic sources. The use of the additive in animal 
nutrition  is  of  no  concern  for  the  safety  of  consumers,  provided  that  the  current  maximum  total 
contents of manganese authorised in feed are respected. 
Handling the additive is a possible hazard to the respiratory tract and the health of users.  In the 
absence of adequate data regarding irritancy to the skin and eyes and dermal sensitisation, the additive 
should be considered as a potential skin and eye irritant and, owing to its residual peptide component, 
as a skin/respiratory sensitiser. 
The use of manganese chelate of amino acids, hydrate, in animal nutrition for all animal species is not 
of  concern for  the  environment,  provided  that  the  current  maximum  total  contents  of  manganese 
authorised in feed are respected.  
The FEEDAP Panel concludes that manganese chelate of amino acids, hydrate, is an effective source 
of manganese for all animal species and categories. 
The FEEDAP Panel made recommendations concerning the description and conditions of use of the 
additive in the registry entry. Manganese chelate of amino acids, hydrate, for all species 
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BACKGROUND 
Regulation (EC) No 1831/2003
1 establishes the rules governing the Community authorisation of 
additives for use in animal nutrition.  In particular, Article 10(2) of that Regulation specifies that 
for existing products within the meaning of Article 10(1), an application  shall be submitted in 
accordance with Article 7, at the latest one year before the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a 
maximum of seven years after the ent ry into force of this Regulation for additives authorised 
without a time limit or pursuant to Directive 82/471/EEC.  
The European Commission received a request from Zinpro Animal Nutrition
2 for re-evaluation of 
authorisation of the  manganese-containing additive manganese chelate of amino acids, hydrate 
(Availa
®Mn), when used as a feed additive for all animal species (category: Nutritional additives; 
functional group: compound of trace elements) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as an application under Article 10(2) 
(re-evaluation  of  an  authorised  feed  additive).  EFSA  received  directly  from  the  applicant  the 
technical dossier in support of this application.
3 According to Article 8 of that Regulation, EFSA, 
after verifying the particulars and documents submitted by the applicant, shall undertake an 
assessment in order to determine whether the feed additive complies with the conditions laid down 
in Article 5. The particulars and documents in support of the application were considered valid by 
EFSA as of 30 of May of 2012. 
The additive “Manganese chelate of amino acids, hydrate” had been authorised in the EU under 
the element Manganese-Mn for all animal species “Without a time limit” (Commission Regulation 
(EC)  No  1334/2003
4  and  amendments,  and  Commission  Regulation  (EC)  No  479/2006 ).
5 
Following the provisions of Article 10(1) of Regulation (EC) No 1831/2003 the  compounds were 
included in the EU Register of Feed Additives under the category “Nutritional additives” and the 
functional group “Compounds of trace elements”.
6 
The  Scientific  Committee  on  Animal  Nutrition  (SCAN)  issued  a  report  on  the  use  of 
manganomanganic oxide in feedingstuffs (EC, 2002). EFSA issued an opinion on the safety of the 
chelated forms of iron, copper, manganese and zinc with synthetic feed grade glycine (EFSA, 
2005), and three opinions on a manganese chelate of hydroxy analogue of methionine (EFSA, 
2008a, 2009, 2010).  
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety  for  the  target  animals,  consumer,  user  and  the  environment  and  the  efficacy  of  the 
Manganese chelate of amino acids, hydrate, when used under the conditions described in Table 1. 
                                                       
1   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for 
use in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
2   Zinpro Animal Nutrition Inc.. Akkerdistel 2E, 5831 PJ-Boxmeer, The Netherlands. 
3   EFSA Dossier reference: FAD-2010-0069. 
4  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
  additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
5  Commission Regulation (EC) No 479/2006 of 23 March 2006 as regards the authorisation of certain additives 
  belonging to the group compounds of trace elements. OJ L 86, 24.3.2006, p. 4. 
6   European  Union  Register  of  Feed  Additives  pursuant  to  Regulation  (EC)  No  1831/2003.  Available  online: 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf Manganese chelate of amino acids, hydrate, for all species 
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Table 1:  Description and conditions of use of the additive as proposed by the applicant    
Additive   Availa
®Mn 
Registration number/EC 
No/No (if appropriate)  - 
Category(-ies) of additive  Nutritional additive 
Functional group(s) of additive  3(b) 
 
Description 
Composition, description 
Chemical formula  Purity 
criteria 
(if 
appropriate) 
Method of analysis 
(if appropriate) 
Manganese Amino Acid 
Chelate, Hydrate 
Mn (x)1-3· nH2O 
(x = anion of any amino acid 
derived 
from hydrolysed soya protein) 
Molecular  weight  not 
exceeding 1 500 
 
8% 
Manganese 
Manganese  assay using The 
product is analysed 
according to the official 
method CEN/TS 
15621:2007; Animal feeding 
stuffs - Determination of 
calcium, sodium, 
phosphorus, magnesium, 
potassium, sulphur, iron, 
zinc, copper, manganese, 
cobalt and molybdenum 
after pressure digestion by 
ICP-AES 
Trade name (if appropriate)  Availa
®Mn 
Name  of  the  holder  of 
authorisation (if appropriate) 
Zinpro Animal Nutrition Inc., The Netherlands 
 
Conditions of use 
Species  or  category 
of animal  Maximum 
age 
Maximum content  Withdrawal  period 
(if appropriate)  mg/kg of complete feedingstuffs 
All species  -  Pet animals   250 (total)  Not relevant 
Fish  200 (total) 
Milk replacers   200 (total) 
Other species  150 (total) 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for use  None 
Specific conditions or restrictions for handling  For  user  safety:  gloves,  respiratory  and  eye 
protection recommended. (see MSDS) 
Post market monitoring  Tracking & tracing will be in full place, all remarks 
during  the  use  of  Availa
®Mn  will  be  noticed  and 
recorded. 
Specific  conditions  for  use  in  complementary 
feedingstuffs 
Availa
®Mn can be mixed in feeds, to supply Mn in 
final feed within EU legal limits for each species.  
 
Maximum Residue Limit (MRL) 
Marker residue  Species  or  category  of 
animal 
Target  tissue(s)  or  food 
products 
Maximum content in the 
tissues 
Non applicable  Non applicable  Non applicable  Non applicable Manganese chelate of amino acids, hydrate, for all species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  an  applicant  involved  in  the 
production/distribution of manganese chelate of amino acids, hydrate. It should be recognised that 
these data cover only a fraction of manganese chelate of amino acids, hydrate, existing on the 
market. The FEEDAP Panel has sought to use the data provided together with data from other 
sources to deliver an opinion.  
The FEEDAP Panel assessment is based on data provided by the applicant for the specific product 
under application, and its conclusions cannot fully be extended to all manganese chelate of amino 
acids, hydrate, in the market. 
1.  Introduction 
Manganese (Mn) is an abundant element which makes up about 0.1 % of the Earth’s crust. It exists 
in a variety of oxidation states, Mn
2+ and Mn
3+ being the most biologically important. Although 
the elemental (metal) form of manganese does not occur naturally in the environment, manganese 
is a component of over 100 minerals (ATSDR, 2012). 
Manganese is an essential nutrient in humans and animals that plays a role in bone mineralization, 
protein  and  energy  metabolism,  metabolic  regulation,  cellular  protection  from  damaging  free 
radical species and formation of glycosaminoglycans (Wedler, 1994).  Manganese acts as both a 
constituent of metalloenzymes and as enzyme activator. Enzymes that contain manganese include 
arginase,  pyruvate  carboxylase  and  manganese-superoxide  dismutase  (NRC,  1989;  Keen  and 
Zidenberg-Cher, 1990; Wedler, 1994). Manganese, in its activating capacity, can bind either to a 
substrate  (such  as  adenosine  triphosphate,  ATP),  or  to  a  protein  directly,  thereby  causing 
conformational changes (Keen and Zidenberg-Cher ,1990). Manganese has been shown to activate 
numerous  enzymes  involved  with  either  a  catalytic  or  regulatory  function  (e.g.  transferases, 
decarboxylases, hydrolases) (Wedler, 1994). 
The application is for the use of manganese chelate of amino acids, hydrate in feed for all animal 
species/categories.  This  manganese  compound  is  already  authorised  in  the  EU  as  nutritional 
additive. 
A  compilation  of  risk  assessments  carried  out  on  manganese  and  its  compounds,  including 
opinions from EFSA’s panels other than the FEEDAP Panel, can be found in Appendix B. A list 
of authorisations of manganese compounds in the EU, other than as feed additive, is reported in 
Appendix C. 
EFSA commissioned the University of Gent (Belgium) to carry out a study of selected trace and 
ultratrace elements in animal nutrition, including manganese. The findings were submitted to the 
EFSA in the form of a technical report (Van Paemel et al., 2010). Information from this report has 
been used in this opinion. 
2.  Identity and characterisation  
For compounds of trace elements, the element itself is considered the active substance. 
Manganese chelate of amino acids, hydrate, has the generic chemical formula Mn(x)1–3·nH2O, 
where x= anion of any amino acids. The compound under application is derived from hydrolysed 
soybean protein, molecular weight not exceeding 1500 Da. 
2.1.  Manufacturing process  
The manufacturing process comprises an acid hydrolysis of soybean protein under heat, followed 
by chelation with manganese (from manganese sulphate). The process is optimised to maximise Manganese chelate of amino acids, hydrate, for all species 
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the release of free amino acids.
7 The final additive is obtained by adding cellulose (4647 %) and 
calcium carbonate (2021 %) to the slurry and subsequent drying. 
The applicant stated that the soybean used in the production of the additive is of conventional 
origin, non-genetically modified, either contractually sourced, or based on an approved geographic 
region.
8 
2.2.  Characterisation of the manganese compound 
The manganese content of five batches of the slurry
9 ranged from 9.5 to 9.7 %.
10 The applicant 
estimated the  molecular weight  of the  compound to be 227–236 Da.
11 Analytical data on one 
sample showed that 94.5 % of the chelated material had a molecular weight < 1500 Da and 5.5 % a 
molecular weight > 1500 Da.
12 The lysinoalanine content in five batches of the hydrolysate was 
below 5 mg/100 g crude protein.
13 The content of heavy metals (lead, cadmium  and mercury), 
fluorine and arsenic analysed in the slurry is in accordance with Directive 2002/32/EC,
14 as are the 
dioxins and the sum of dioxins plus dioxin -like  polychlorinated biphenyls  (PCBs)  (all values 
derived from three batches).
15 
Analytical data on five batches of the hydrolysate material before the addition of the  manganese 
source showed that at least about 95 % of the total amino acid content is present in the form of free 
amino acids.
16 
2.3.  Characterisation of the additive 
The final product is specified to contain a minimum of 8 % manganese, as confirmed by analysis 
of five batches (range: 8.078.56 % manganese).
17 Proximate analysis of  one batch revealed a 
content of 3.1 % moisture, 20.1 % crude protein, 1.25 % lipids, 9.5 % crude fibre and 40.4 % ash; 
the product also contains per kilogram additive: 30 g sulphur, 20.4 g sodium, 57.1 g calcium, 3.0 g 
potassium and 0.8 g phosphorus.
18 
Heavy metals (lead, cadmium and mercury), fluorine and arsenic complied with the limits set  in 
Directive 2002/32/EC, as did dioxins and the sum of dioxins plus dioxin -like PCBs (all values 
derived from three batches).
19 The nickel content (five batches) was between 5 and 17 mg/kg.
20  In 
three  batches  Escherichia  coli  O157:H7  and  Salmonella  (25  g  sample  of  the  product)  were 
absent.
21 In three batches, aflatoxin content was less than 4 µg/kg and ochratoxin ranged from < 4 
to 6.8 µg/kg.
22 
2.4.  Physical state of the additive 
The product is a coarse granular powder. It is reported to be insoluble in water. Bulk density is 660 
kg/m
3.  
                                                       
7  Technical Dossier/Supplementary Information. 
8  Technical Dossier/Supplementary Information. 
9  Slurry means the intermediate product of manganese chelation with the protein hydrolysate. 
10   Technical Dossier/Supplementary Information. 
11   Technical Dossier/ Supplementary Information. 
12   Technical Dossier/Supplementary Information. 
13   Technical Dossier/Supplementary Information. 
14   Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in 
  animal feed. OJ L 140, 30.5.2002, p. 10. 
15   Technical Dossier/Supplementary Information. 
16   Technical Dossier/Supplementary Information. 
17   Technical Dossier/Section II. 
18   Technical Dossier/Section II/Annex II_ 2_a. 
19   Technical Dossier/Section II/Annex II_ 2_b (Five annexes). 
20   Technical Dossier/Supplementary Information. 
21   Technical Dossier/Section II. 
22   Technical Dossier/Supplementary Information. Manganese chelate of amino acids, hydrate, for all species 
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Sieve analysis of one batch identified that 2 % (w/w) of particles had a diameter below 180 µm.
23 
At the  request of the FEEDAP Panel, sieve analysis was repeated in three other batches , and 
revealed the fraction below 75 µm to be 2.81–4.2 % (w/w).
24 No data on dusting potential were 
provided.  
2.5.  Stability  
No  data  were  provided  for  the  manganese  chelate  amino  acids,  hydrate.  Information  on  the 
maintenance of the specific manganese bonds in the chelates would be valuable. The FEEDAP 
Panel recognises the analytical difficulties in demonstrating stability of this specific bond and 
notes that the active substance is also unlikely to disappear in these products. 
2.6.  Homogeneity  
The potential homogeneous distribution of the additive was predicted using a statistical approach  
(Jansen,  1992)  in  the  case  of  a  complete  feed  for  chickens  for  fattening.  The  coefficient  of 
variation was 4.5 %.
25 However, the FEEDAP Panel notes that this method has been developed to 
test the working accuracy of mixing equipment, and its applicability to test homogeneity has not 
been demonstrated.  
2.7.  Physico-chemical incompatibilities in feed  
Based  on  current  knowledge,  no  incompatibilities  resulting  from  the  use  of  manganese  in 
compound  feed  are  expected,  other  than  those  widely  known  and  considered  by  feed 
manufacturers when formulating diets. 
2.8.  Conditions of use 
Manganese chelate of amino acids, hydrate is intended for use in feed for all animal species and 
categories without time restrictions. The proposed total concentration of manganese in complete 
feed (fish, 100 mg/kg; all other species, 150 mg/kg) comply with the current legislation.
26  
2.9.  Evaluation of the analytical methods by the European Union Reference Laboratory 
(EURL) 
EFSA  has  verified  the  EURL  report  as  it  relates  to  the  methods  used  for  the  control  of  the 
manganese (six compounds, including manganese chelate of amino acids, hydrate) in animal feed. 
The Executive Summary of the EURL report can be found in Appendix A. 
3.  Safety 
3.1.  Safety for the target species  
Tolerance studies are not required for compounds of trace elements already authorised (Regulation 
(EC) No 429/2008).
27 The assessment of manganese safety  for the target species is based on a 
previous opinion of the Scientific Committee on Food  (SCF) (EC, 2000) and on more recent 
FEEDAP Panel opinions (2009, 2010). 
Manganese is an essential trace element. Its essentiality in livestock nutrition (poultry) became 
already in the 1930s (Lyons and Insko, 1937; Wilgus et al. 1937; Schaible et al. 1938).  
                                                       
23   Technical Dossier/Section II. 
24   Technical Dossier/Supplementary Information. 
25   Technical Dossier/Section II. 
26   The FEEDAP Panel notes that the figures reported in Table 1, Conditions of Use, are incorrect. 
27   Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation 
  (EC) No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of 
  applications and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008. Manganese chelate of amino acids, hydrate, for all species 
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Manganese has a long history of safe use. In general, manganese is considered to be one of the 
least toxic essential trace elements for farm animals. Depressed iron status and haematological 
changes  are  the  most  common  signs  of  manganese  toxicosis,  also  observed  in  animals  fed 
adequate levels of iron (NRC, 2005). The National Research Council defined in 2005 maximum 
tolerable levels (MTLs, in mg/kg DM) for ruminants and poultry (2000), pigs (1000) and horses 
(400), whereas no MTL could be derived for fish because of insufficient data (NRC, 2005). The 
current authorised maximum total contents in complete feed in the EU (100 mg/kg for fish and 150 
mg/kg for other animal species) provides a sufficient margin of safety to the MTLs as well as a 
sufficient margin of safety to the allowances, with estimated requirements for chicken and turkeys 
for fattening of 60 mg/kg, for laying hens of 30 mg/kg, for pigs and cattle of 1525 mg/kg (GfE, 
1999, 2001, 2008; NRC, 1994, 2001; Suttle, 2010). 
Since the additive contains nickel as contaminant,  the FEEDAP Panel assessed the impact of 
nickel on safety for the target species. Considering the background levels in animal feed as 500–
4000  µg/kg  DM  feed  (Nicholson  et  al.,  1999;  Van  Paemel  et  al.,  2010),  nickel  would  be 
incorporated  by  supplementing  feeds  with  manganese  chelate  of  amino  acids,  hydrate,  at 
extremely low quantities, that is ~21 μg Ni/kg fish feed (when adding 100 mg manganese from 
manganese  chelate  of  amino  acids,  hydrate)  and  ~32  μg  Ni/kg  feed  for  other  animal 
species/categories  (when  adding  150  mg  manganese  from  manganese  chelate  of  amino  acids, 
hydrate).  Therefore,  no  concerns  for  the  safety  of  the  target  animals  would  arise  from  this 
particular aspect. 
3.1.1.  Microbiological studies 
The antimicrobial resistance conferred by the presence of manganese in the additive was tested 
against  five  tetracycline-sensitive  microbial  strains  (Escherichia  coli  ATCC  25922, 
Staphylococcus  aureus  ATCC  25923,  Enterococcus  faecalis  ATCC  29212,  Pseudomonas 
aeruginosa  ATCC  27853,  Bacillus  subtilis  ATCC  6633,  as  recommended  by  the  FEEDAP 
Guidance on Microbial Studies; EFSA, 2008b). The minimum inhibitory concentration for all five 
strains was above 200 mg Mn/L, the highest tested manganese concentration.
28 
3.1.2.  Interactions 
Manganese  and  iron  compete  for  absorption  sites.  Fibre,  phytate,  calcium,  phosphorus  and 
magnesium may also interfere with manganese absorption. 
3.1.3.  Conclusions on the safety for species  
Manganese  chelate  of  amino  acids,  hydrate,  is  considered  a  safe  additive  for  all  animal 
species/categories, provided that the current maximum total contents of manganese authorised in 
feed are respected, that is, 100 mg/kg complete feedingstuffs for fish and 150 mg/kg for other 
species. 
3.2.  Safety for the consumer 
3.2.1.  Metabolic and residue studies  
Manganese is absorbed through the small intestine by nonsaturable simple diffusion (Bell et al., 
1989) or by a carrier-mediated transport mechanism with high affinity and low capacity (Garcia-
Aranda  et  al.,  1983).  The  absorption  rate  depends  on  the  amount  present  in  the  gut.  Typical 
apparent absorption may be in the range of 35 %, however, values as high as 40 % have been 
observed in veal calves with a supply of only 0.6 mg Mn/kg milk replacer (Kirchgessner and 
Neese,  1976)  Absorption  in  poultry  is  lower,  explaining  the  higher  requirement.  Intestinal 
absorption of manganese is also inversely related to iron intake (Lönnerdal, 1997). Manganese 
absorbed into portal circulation is transported by α2-macroglobulins or albumin to the liver. The 
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major portion of manganese in the liver is secreted into bile. Consequently manganese is primarily 
excreted  via  faeces.  Urinary  excretion  of  manganese  is  a  minor  route  of  excretion;  it  is  of 
endogenous nature and therefore not related to the dietary intake (NRC, 2005). 
The highest concentrations of manganese are found in the liver, pancreas and kidney and the 
lowest levels occur in bone and fat. Nevertheless, manganese deposition in none of these tissues is 
considered a valuable indicator of manganese availability in the gut (Jongbloed et al., 2002). 
3.2.2.  Manganese deposition studies  
Although following Commission Regulation (EC) No 429/2008 residue/deposition studies are not 
required for an already approved compound of trace elements, the applicant provided several peer-
reviewed studies. 
3.2.2.1.  Studies with manganese chelate of amino acids, hydrate, under application   
In an experiment with the aim of investigating the influence of different trace elements on egg 
shell quality, laying hens were fed a maize-soybean diet containing 24.7 mg Mn/kg as such and 
supplemented with 30 and 60 mg Mn/kg from either manganese chelate of amino acids, hydrate, 
or manganous oxide for nine weeks (Mabe et al., 2003). The manganese concentration in the egg 
yolk was measured. The final results are listed in Table 2. 
Table 2:  Manganese egg yolk deposition from manganese chelate of amino acids, hydrate, and 
manganous oxide 
 
 
Manganese source 
None (control)  Manganous oxide  Manganese chelate of amino acids, 
hydrate 
Supplemental Mn (mg Mn/kg)  0  30  60  30  60 
Feed (mg Mn/kg), analysed  24.7  53.8  76.9  51.2  78.6 
Egg yolk (mg Mn/kg)  0.63
b  0.79
ab  0.93
a  0.72
ab  0.94
a 
a, b: Means with different superscript within a row are significantly different (P<0.05). 
The data show a dose dependent significant increase in the manganese concentration of the egg 
yolk without differences due to the manganese source.  
Other studies in cows reported no differences in liver deposition when up to 14 % of supplemental 
manganese from manganese sulphate was replaced by manganese chelate of amino acids, hydrate 
(Ballantine et al., 2002; Siciliano-Jones et al., 2008). 
3.2.2.2.  Studies with manganese chelate of amino acids, hydrate, of other origin 
Following a request from EFSA, the applicant performed a literature search for peer-reviewed 
articles published between January 2003 and November 2012 on the potential differences in the 
deposition of manganese from inorganic and organic sources in edible tissues and products.
29 The 
databases  used  for  this  research  were  Medline,  F ood  Science  and  Technology,  Agricola, 
Biological Abstracts, Embase, Medline preprints and Life science coll ections, and included the 
applicant‘s  own  database.  The  keywords  applied  were  reported.  Since  the  bioavailability  and 
retention  of  manganese  can  vary  between  different  organic  forms,  only  the  studies  in  which 
manganese chelate of amino acids, hydrate, was administered were considered by the FEEDAP 
Panel to compare the manganese edible tissue/animal products deposition with that of manganese 
sulphate as standard inorganic manganese source. 
No studies were found for dairy milk. The data on eggs have already been described above (Mabe 
et al., 2003). 
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Lu et al. (2007) conducted a 42-day experiment using a total of 336 one-day-old Arbor Acres 
commercial  male  chickens  for  fattening  to  investigate  the  effect  of  dietary  manganese 
supplementation on muscle deposition among other endpoints. Broilers were randomly allotted by 
body weight to one of eight replicate cages (six chicks per cage) for each of the seven treatments 
in a completely randomized design. Dietary treatments included the maize-soybean based diet 
(control) and the basal diet supplemented with 100 or 200 mg Mn/kg as  manganous sulphate 
monohydrate, and two manganese chelates of amino acids of different chelation strength. The 
basal  diets  (starter  and  grower)  contained  about  20  mg  Mn/kg,  the  diets  supplemented  with 
manganese contained either 100 mg Mn/kg or 200 mg Mn/kg. Breast and leg muscle tissue of the 
control birds contained 0.45 and 0.40 mg Mn/kg fresh tissue. The addition of 100 and 200 mg 
Mn/kg diet increased the  manganese concentration in  muscle only slightly (to about 0.49 mg 
Mn/kg and to 0.44 mg Mn/kg in both muscle tissues, respectively). The manganese contents in 
breast and leg muscles after addition of manganese sulphate were 0.47 and 0.42 mg/kg; after the 
addition of both manganese chelates the manganese contents in breast and leg muscles were 0.48 
and 0.43 mg Mn/kg, respectively. 
Nocek et al. (2006) supplied trace minerals to lactating dairy cows (n=573 multi-parity) in either 
inorganic or organic form. Manganese was supplied as (1) an organic source (manganese chelate 
of amino acid) at 75 % of NRC (2001) requirements (about 14 mg Mn/kg DM); (2) an inorganic 
source (manganous sulphate) at 100 % NRC (2001) requirements (about 18 mg Mn/kg DM); (3) an 
organic source (manganese chelate) at 100 % of NRC (2001) requirements; and (4) a combination 
of organic and inorganic forms with manganese at 330 % of NRC (2001) requirements (about 65 
mg Mn/kg DM, of which 16 mg were from manganese chelate). All percentages of zinc, copper, 
manganese, and cobalt relative to NRC (2001) requirements reflect supplemental contributions and 
do not include basal diet contributions (calculated 26 mg Mn/kg DM lactation diet). Liver biopsies 
were collected from the same 30 cows per treatment at three times during the trial: trial initiation, 
150 days into lactation period 1, and 150 days into lactation period 2. There was no treatment 
effect (P> 0.05) on the liver manganese concentration (average 9.4 mg Mn/kg liver DM). 
In a 40-week study, DeFrain et al. (2010) reported liver manganese concentrations in lactating 
dairy cows supplemented with 200 mg Mn/day from manganese chelate of amino acids, hydrate. 
Liver manganese concentrations were determined at week 21 and week 40 via liver biopsies. Liver 
manganese  was  not  affected  (P>  0.05)  by  manganese  supplementation.  Liver  manganese 
concentrations were 3.72 mg/kg for the unsupplemented control animals and 4.24 mg/kg for the 
supplemented cows at week 21 and were similar at week 40 (3.54 mg/kg and 3.62 mg/kg for the 
control and treated cows, respectively). 
Li et al. published two studies (Li et al., 2004, 2005) on bone manganese concentrations in chicks 
fed diets supplemented with 0, 60, 120 or 180 mg Mn/kg. Experiment 1 with 546 chicks, lasted 42 
days; experiment 2 with 624 chicks, lasted 21 days. In both experiments, manganous sulphate was 
compared with two manganese chelates of amino acids of different chelation strengths (Qf values 
45.3 and 115.4). Birds were sacrificed for tissue collection in experiment 1 on days 21 and 42 and 
in experiment 2 after 21 days. In both experiments, bone manganese concentrations did not differ 
(P> 0.05) between manganese sources (and on either collection day in experiment 1). Manganese 
concentrations after 21 days treatment in bone ash were between 10.5 and 10.9 mg/kg for the 
supplemented groups in experiment 1 (control 5.5 mg/kg) and between 11.73 mg/kg and 12.05 mg 
Mn/kg in experiment 2 (control:6.2 mg Mn/kg). 
3.2.2.3.  Conclusion on manganese deposition in tissues and products  
The available data on manganese deposition in muscle, liver, bone and egg yolk analysed after 
administration of manganese chelate of amino acids, hydrate, and inorganic manganese sources 
(mostly manganous sulphate) allow the conclusion, that feeding the organic source at levels within 
the range of the maximum contents authorised in the EU does not result in higher deposition in Manganese chelate of amino acids, hydrate, for all species 
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animal tissues and egg yolk. Based on current knowledge on manganese metabolic pathways, this 
conclusion could also be drawn for milk.  
3.2.3.  Toxicological profile of manganese 
Manganese is essential in the nutrition of both animals and humans. No toxicological studies were 
provided by the applicant. The FEEDAP Panel reviewed the relevant literature and considered 
several  previous  toxicological  assessments  of  manganese.  It  is  noted  that  there  are  relatively 
limited data available on oral toxicity in laboratory animals and humans. 
3.2.3.1.  Toxicological reviews 
As is the case for all transition metals, long-term exposure to high doses of manganese poses a 
risk. The toxicology of manganese has been reviewed by the SCF (EC, 2000), the UK Expert 
Group on Vitamins and Minerals (EVM 2002, 2003), the US Environmental Protection Agency 
(EPA, 2003), the UK Institute of Environment and Health (IEH, 2007), and most recently the US 
Agency for Toxic Substances and Disease Registry (ATSDR, 2012). There is a consensus that the 
main toxic effects of manganese in humans concern the nervous system, the respiratory system 
(inhalatory exposure) and, to a lesser extent, the reproductive system. 
Chronic severe toxicity is primarily associated with effects on the central nervous system (CNS), 
especially through inhalation and long-term exposure, and is considered much more relevant than 
acute effects (Huang et al., 1989; cited by IEH, 2007). Common neurological symptoms arising 
from chronic manganism tend to occur in phases and start with anorexia, weakness and apathy, 
followed by a second phase of hallucinations, delusions and insomnia. During the later stages of 
chronic toxicity, Parkinson-like symptoms such as tremor and muscle rigidity take place. Although 
manganism and true idiopathic Parkinson disease cause very similar deficits within the CNS, they 
differ in the neurotransmitters upon which they act; manganese toxicity results principally in the 
degeneration of GABAergic neurones in the globus pallidus whilst Parkinson disease is more 
associated with the dopaminergic neurons in the basal ganglia (Roth, 2006; cited by IEH, 2007).  
Manganese  aggregates  into  non-haem  iron  regions  of  the  brain  such  as  the  globus  pallidus, 
substantia nigra and subthalamic nuclei (Aschner et al., 2007). Although the precise mechanisms 
by which manganese induces toxic effects within the CNS are a matter of continuing debate, there 
are a number of reports which highlight possible interactions between manganese and other trace 
elements such as iron, copper, and aluminium (IEH, 2007). Postulated mechanisms of manganese-
induced neurotoxicity include (i) increased production of reactive oxygen species (Cohen, 1984; 
cited  by  IEH,  2007),  (ii)  neuronal  degeneration  by  means  of  activation  of  glutamate-gated 
channels (Brouillet et al., 1993; cited by IEH, 2007), (iii) manganese in a divalent (or higher) 
oxidation state exerting toxicity on dopamine (Archibald and Tyree, 1987; cited by IEH, 2007), 
(iv) dopamine oxidation by manganese causing oxidative DNA damage (Oikawa et al., 2006, cited 
by IEH, 2007) and (v) production of 6-hydroxydopamine (or other toxic catecholamines; Graham, 
1984; cited by IEH, 2007). A recent publication focuses on dopamine oxidation and mitochondrial 
damage as the main mode of action (Farina et al., 2013). 
There are association studies suggesting that, as in animal models, excess manganese exposure in 
humans  can  lead  to  reproductive  toxicity  resulting  in  decreased  fertility  and  increased  foetal 
abnormalities (Lauwerys et al., 1985; cited by IEH, 2007; Crossgrove and Zheng, 2004; cited by 
IEH, 2007). For example, in one study manganese-exposed male workers were found to have 
fewer children than others (Lauwerys et al., 1985; cited by IEH, 2007). However, other studies did 
not find the same effect (IEH, 2007). 
The results of in vitro studies show that at least some chemical forms of manganese (manganese 
chelate of amino acids, hydrate, not tested) have mutagenic potential (ATSDR, 2012). The issue of 
manganese  genotoxicity  has  been  recently  reconsidered  by  Lima  et  al.  (2011);  available  data 
confirm that manganese can exert genotoxic effects in human lymphocytes ex vivo without any Manganese chelate of amino acids, hydrate, for all species 
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marked  concurrent  cytotoxicity.  Likely  mechanisms  include  oxidative  damage  (as  a  transition 
metal, manganese is a potential reactive oxygen species inducer) and the interaction with DNA 
polymerases and other proteins involved with DNA-dependent processes (Wafik et al., 1984). The 
results of in vivo studies in rodents are inconsistent, and in its assessment of manganese ATSDR 
(2012) was unable to draw an overall conclusion about the possible genotoxic hazard to humans 
from exposure to manganese compounds.  
Information  on  in  vivo  chronic  toxicity  of  manganese  comes  from  the  National  Toxicology 
program (NTP) which conducted two chronic studies in rats and mice (NTP, 1993). F344/N rats 
were exposed orally for two years to  manganese from manganous sulphate at 60, 200 or 465 
mg/kg body weight (bw) (males) or 70, 230 or 714 mg/kg bw (females). Under the conditions of 
this  2-year  feeding  study,  there  was  no  evidence  of  carcinogenic  activity  of  manganese  (II) 
sulphate monohydrate in male or female rats (NTP, 1993). In a 2-year study in B6C3F1 mice, the 
animals were exposed orally to 160, 540 or 1800 mg Mn/kg bw (males) or 200, 700 or 2250 mg 
Mn/kg bw (females). There was equivocal evidence
30 of carcinogenic activity of manganese (II) 
sulphate monohydrate in male and female mice, based on  a marginally increased incidence of 
thyroid gland follicular cell adenoma and  a significantly increased incidence of follicular cell 
hyperplasia.  The  ingestion  of  diets  containing  manganese  (II)  sulphate  monohydrate  was 
associated with focal squamous hyperplasia of the forestomach i n male and female mice, and 
ulcers and inflammation of the forestomach in male mice. EVM (2002) echoed the conclusions by 
NTP (1993) and stated that “Chronic carcinogenicity studies of manganese sulphate in mice and 
rats were essentially negative, with equivocal evidence of carcinogenicity being observed in mice 
only”. There is no epidemiological or other evidence that manganese causes cancer in humans 
(ATSDR, 2012).  
As manganese is an essential element, oral exposure is not only unavoidable, but necessary to 
meet nutritional requirements. 
3.2.4.  Assessment of consumer safety  
Ingested manganese appears to be well tolerated in humans and manganese intake is generally low 
(mean  4.9  mg/day;  EVM,  2003).  The  general  population  is  exposed  to  manganese  through 
consumption of food and water, inhalation of air, and dermal contact with air, water, soil, and 
consumer products that contain manganese. The primary source of manganese intake is through 
the diet (ATSDR, 2012).  
Anaemic  individuals  may  be  vulnerable  to  the  toxic  effects  of  manganese  as  a  result  of  the 
increased  absorption  that  occurs  in  states  of  iron  deficiency.  Groups  with  impaired  biliary 
clearance,  such  as  patients  with  liver  disease  or  elderly  people,  may  also  be  susceptible  to 
manganese accumulation and toxicity. It has also been reported that ethanol and long-term use of 
anti-psychotic drugs increases the susceptibility of humans to manganese toxicity (EVM, 2002). 
The SCF (EC, 2000) could not conclude about a tolerable upper intake level (UL) of manganese 
owing  to  significant  data  gaps.  Correspondingly,  the  ATSDR  (2012)  could  not  establish  oral 
Minimal Risk Levels for acute, intermediate, or chronic duration of oral exposure to manganese. 
However, a Tolerable Upper Intake Level for adults of 11 mg manganese/day has been set by the 
US Food and Nutrition Board of the Institute of Medicine (FNB/IOM, 2001) based on an estimate 
that people eating vegetarian or Western-style diets consume up to 10.9 mg  Mn/day with no 
reports of adverse effects (Greger, 1999). No recommended dietary allowance has been defined 
for  manganese.  The  FNB/IOM  (2001)  has  set  adequate  intake  (AI)  levels  for  manganese  for 
humans. The AIs are 2.3 and 1.8 mg/day for males and females, respectively, and 1.2 mg/day for 
toddlers. Based on the dietary intake plus 4 mg/person per day from supplements, the EVM (2003) 
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estimated a guidance value of 0.2 mg Mn/kg bw per day, corresponding to 12 mg/day for a 60-kg 
person. The guidance value for older people (60 kg bw) is 0.15 mg/kg bw. 
The normal dietary intake is calculated to be approximately 25 mg/day (Jankovic, 2005; cited by 
IEH, 2007). This is in line with older data reviewed by the SCF (EC, 2000) and the EVM (2003). 
The dietary intake of adults has been estimated to range from 0.9 to 7 mg Mn/day (Schlettwein-
Gsell and Mommsen-Straub, 1973; cited by EC, 2000), 2 to 9 mg Mn/day (WHO-IPCS, 1981; 
cited by EC, 2000) and 1.2 to 9.4 mg Mn/day (Ellen et al., 1990; cited by EC, 2000). A Total Diet 
Study showed that the estimated average intake of manganese in the UK population in 1994 was 
4.9 mg/day (97.5th percentile: 8.2 mg/day), including 2.3 mg/day from beverages (MAFF, 1997; 
cited by EC, 2000).  
According to EPA (2003) “Nuts and nut products contain between 18.2 and 46.8 mg Mn/kg, grain 
and grain products between 0.4 and 40.7 mg, legumes between 2.2 and 6.7 mg, fruits between 0.2 
and 10.4 mg, vegetables and vegetable products between 0.4 and 6.6 mg, meat (poultry, fish, eggs) 
between  0.1  and  4.0  mg,  milk  and  milk  products  between  0.02  and  0.49  mg  Mn/kg”.  The 
manganese content in food is in the same order of magnitude as those reported by Souci et al. 
(2008), who reported the following (values represent the range of averages for several animal 
species): milk, 0.025–0.068; muscle, 0.13–0.38; heart, brain and kidney, 0.24–1.50; and liver, 
2.80–3.30 mg/kg fresh matter. 
Manganese intake can be higher in vegetarians because higher levels of manganese occur in food 
of plant origin. Tea drinkers are a potential high-intake group (a cup of tea can contain 0.41.3 mg 
manganese (WHO, 1996; cited by EC, 2000; the manganese content of black tea is reported to be 
730 mg/kg dried tea (Souci et al., 2008)), although the bioavailability of manganese in tea is 
unclear and may be low owing to the presence of tannins. Many individuals who do not consume 
whole grains, nuts, certain fruits (pineapple), green leafy vegetables and tea will consume a “low-
manganese” diet —less than 2 mg per day (Davis et al., 1992; cited by EPA, 2003).  
The SCF (EC, 2000) noted that the available data indicate that, in both humans and experimental 
animals,  the  margin  between  oral  effect  levels  and  the  estimated  intake  from  food  is  low, 
suggesting that oral exposure to manganese beyond that normally present in food and beverages 
could represent a risk of adverse health effects without evidence of any health benefit. 
Since supplementation of feed for food-producing animals has a long history of use, it is suggested 
that  the  intake  data  referred  to  above  include  food  originating  from  animals  reared  with 
manganese-supplemented feed. Manganous oxide and manganous sulphate are commonly used 
inorganic sources of manganese feed supplementation. It was shown that manganese chelate of 
amino acids, hydrate, does not lead to higher manganese deposition in tissues and products of 
animal origin, compared to these inorganic sources of manganese supplementation. The level of 
manganese intake resulting from the consumption of tissues and products of animal origin is not of 
concern  for  the  safety  of  consumers,  including  more  sensitive  subgroups  such  as  infants  and 
elderly people.  
3.2.5.  Conclusions on safety for consumers 
Generally,  dietary  manganese  does  not  appear  to  cause  any  unwanted  health  effects  in  the 
population and has not proven to be a risk at usual intake levels. Manganese intake resulting from 
the consumption of tissues and products of animal origin is low and is not of concern for the safety 
of consumers including more sensitive subgroups such as infants and elderly people. The use of 
manganese chelate of amino acids, hydrate, does not result in higher manganese deposition in 
edible tissues and products than the standard inorganic sources. It is concluded that the use of the 
additive in animal nutrition is of no concern for the safety of consumers, provided that the current 
maximum total contents of manganese authorised in feed are respected. Manganese chelate of amino acids, hydrate, for all species 
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3.3.  Safety for the users/workers  
Manganese is a recognised workplace toxicant upon inhalation exposure. Inhalation of manganese 
results  in  pulmonary  oedema  and  tracheobronchitis  (Nemery,  1990;  cited  by  IEH,  2007). 
Furthermore, inhaled manganese is particularly hazardous as it can be transported directly to the 
brain  bypassing  the  liver  metabolism  (ATSDR,  2012).  Some  studies  suggest  that  manganese 
inhalation can result in adverse cognitive effects, such as attention deficit and amnesia (ATSDR, 
2012). Individuals subject to prolonged occupational exposure to high levels of manganese are 
considered  to  be  most  at  risk.  Thus,  welders,  miners  and  other  metal  industry  workers  have 
exhibited increased incidences of pulmonary conditions such as pneumonia and bronchitis (Saric 
and Piasek, 2000; cited by IEH, 2007). The lung epithelium functions as a barrier to infection and 
its ability to respond to foreign antigens is disrupted in the presence of manganese along with 
many  other  transition  metals.  In  a  study  by  Roth  and  Garrick  (2003;  cited  by  IEH,  2007), 
manganese  was  regarded  as  the  second  most  important  metal,  after  copper,  in  causing 
inflammation of the lung tissue. This inflammation is thought to occur by means of cytokine 
release (interleukins) as opposed to being immunoglobulin (IgE) mediated.  
The FEEDAP Panel concludes that handling the additive is a possible hazard to the respiratory 
tract and the health of users. In the absence of adequate data regarding irritancy to the skin and 
eyes, and dermal sensitisation, the additive should be considered as a potential skin and eye irritant 
and, owing to its residual peptide component, as a skin/respiratory sensitiser.  
3.4.  Safety for the environment  
Manganese is the second most abundant (after iron) transition element in the Earth’s crust, with an 
estimated  global  average  in  soil  of  437  mg/kg  (Forum  of  European  Geological  Surveys, 
FOREGS).
31 The median concentration of manganous oxide in 845 samples of to psoil collected 
throughout Europe for the FOREGS survey was 650 mg/kg and the manganese content of the acid 
soluble fraction (Aqua regia) contained 382 mg/kg, with a range of < 106480 mg/kg (FOREGS). 
The behaviour of manganese in soil is very complex and is controlled by different environmental 
factors, of which pH-Eh conditions are the most important (Kabata-Pendias 2001). Mn
2+ appears 
to have low affinity for organic ligands (Lazerte and Burling, 1990; Chiswell and Zaw 1991). 
However, whilst the Mn
2+ (aqueous) ion is readily soluble, manganese in soil is not very mobile, 
because Mn
3+ and Mn
4+ form insoluble hydrous oxides, especially under oxidising conditions. 
Concentrations  of  dissolved  manganese  in  European  stream  waters  from  the FOREGS  survey 
range from < 0.05 to 698 μg/L, with a median value of 15.9 μg/L (n= 804). The lowest values of 
dissolved manganese (< 1.7 μg/L) are found in central and northern Sweden, in central and south 
Norway, and in western Scotland and western England on Caledonian terrains (FOREGS). 
3.4.1.  Environmental safety from use in feeds for terrestrial farm animals 
Based on the calculation method provided in the technical guidance for assessing the safety of feed 
additives for the environment (EFSA, 2008c), the highest theoretical addition of manganese in soil 
(PECsoil)  from  animal  feeds  is  around  3  mg/kg  (lambs)  after  a  1-year  application  of  manure 
assuming that 100 % of a dose will be excreted. As the median content of manganese in European 
soil is over two orders of magnitude higher than this value, the use of manganese in animal feeds 
at the legislated inclusion levels is not expected to pose a risk to the soil compartment.  
Following the technical guidance and further assuming that manganese chelate of amino acids, 
hydrate,  will  be  completely  dissociated  in  the  gut  and  solubilised  to  Mn
2+,  the  predicted 
concentrations of manganese in surface water (PECsw) would range from 332 to 630 μg/L, with the 
highest concentrations resulting from the use of manganese chelate of amino acids, hydrate in feed 
for lambs and chickens for fattening. This worst-case scenario suggests that supplementation of 
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animal  feeds  with  manganese  chelate  of  amino  acids,  hydrate,  would  markedly  increase  the 
background concentrations of manganese in surface waters. However, this outcome is considered 
unrealistic  because  the  calculated  worst-case  PECsoil  is  much  lower  than  background 
concentrations, and it is likely that manganese added to the soil through the spreading of manure 
would oxidise to insoluble (III) and (IV) forms and otherwise  would behave similarly to that 
naturally  present.  Thus,  the  use  of  manganese  chelate  of  amino  acids,  hydrate,  in  feeds  for 
terrestrial animals up to a concentration of 150 mg/kg complete feed is considered safe to the 
aquatic compartment. 
3.4.2.  Environmental safety from use in aquaculture feeds 
Using its technical guidance for assessing the safety of feed additives for the environment (EFSA, 
2008c), the FEEDAP Panel calculated the worst-case concentrations in the environment resulting 
from the supplementation of fish feeds with manganese chelate of amino acids, hydrate, at the total 
level of 100 mg Mn/kg. When fed to fish in seacages, the sediment under the cage is considered 
the compartment of concern (EFSA, 2008c). The PECsed was calculated to be 212 μg/kg wet 
weight, which substantially exceeds the threshold for Phase I assessment (10 μg/kg). However, 
manganese concentrations in top sediment in marine and estuarine environments vary widely from 
10  to  at  least  4000  mg/kg,  which  in  all  cases  by  far  exceed  that  maximally  emitted  from 
aquaculture (Sadiq and Zaidi, 1985; Cahill and Unger, 1993; Galasso et al., 2000; Sahli et al., 
2011).  For  land-based  aquaculture  operations,  such as  ponds  and raceways,  the  surface  water 
downstream of the fish farm is considered the most sensitive compartment (EFSA, 2008c). The 
PECswaq was calculated to be 1.02.0 μg/L, depending on the species. This concentration exceeds 
the trigger value by one order of magnitude, but is also one order of magnitude lower than the 
median concentration of manganese in European freshwaters (FOREGS).  
3.4.3.  Conclusions on safety for the environment 
The use of manganese chelate of amino acids, hydrate, in animal nutrition for all animal species is 
safe  for  the  environment,  provided  that  the  current  maximum  total  contents  of  manganese 
authorised in feed are respected.   
4.  Efficacy  
Manganese  chelate  of  amino  acids,  hydrate,  is  a  currently  authorised  compound  of  the  trace 
element Manganese. According to Commission Regulation (EC) No 429/2008, no efficacy studies 
are required for compounds of trace elements already authorised as feed additives. The product has 
been used for many years in the EU and has been proven to be an available source of manganese 
under practical conditions in different species.  
The use of manganese chelate of amino acids, hydrate, in animal nutrition is documented in the 
scientific literature (e.g. Ballantine et al., 2002; Mabe et al., 2003; Li et al., 2004, 2005; Nocek et 
al., 2006; Lu et al., 2007; Toni et al., 2007; Siciliano-Jones et al., 2008; Hackbart et al., 2010; 
Suttle,  2010).  It  is  recognised  as  an  efficacious  source  of  manganese  in  meeting  the  animal 
requirements.  
The FEEDAP Panel concludes that manganese chelate of amino acids, hydrate, is an effective 
source of manganese for all animal species and categories. Manganese chelate of amino acids, hydrate, for all species 
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5.  Post-market monitoring 
The FEEDAP Panel considers that there is no need for specific requirements for a post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
32  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Manganese  chelate  of  amino  acids,  hydrate  is  considered  a  safe  additive  for  all  animal 
species/categories, provided that the current maximum total contents of manganese authorised in 
feed are respected, that is, 100 mg/kg complete feedingstuffs for fish and 150 mg/kg for other 
species.. 
Dietary manganese does not appear to cause any adverse effects in consumers at usual intake 
levels. Manganese intake resulting from the consumption of tissues and products of animal origin 
is low compared with the intake resulting from the consumption of food of plant origin. The use of 
manganese chelate of amino acids, hydrate, does not result in higher manganese deposition in 
edible tissues and products than that resulting from commonly used inorganic sources. The use of 
the additive in animal nutrition is of no concern for the safety of consumers, provided that the 
current maximum total contents of manganese authorised in feed are respected. 
Handling the additive is a possible hazard to the respiratory tract and the health of users. In the 
absence of adequate data regarding irritancy to the skin and eyes, and dermal sensitisation, the 
additive should be considered as a potential skin and eye irritant and, owing to its residual peptide 
component, as a skin/respiratory sensitiser.  
The use of manganese chelate of amino acids, hydrate, in animal nutrition for all animal species is 
safe  for  the  environment,  provided  that  the  current  maximum  total  contents  of  manganese 
authorised in feed are respected.  
The FEEDAP Panel concludes that manganese chelate of amino acids, hydrate, is an effective 
source of manganese for all animal species and categories. 
RECOMMENDATIONS 
The Description and conditions of use of the additive as proposed by the applicant should be 
amended as follows: 
  The Description of the product proposed by the applicant should be amended as follows: 
Mn (x)1-3·nH2O (x= anion of any amino acid derived from acid hydrolysed soya protein). 
At  least  90 %  of  the  molecules  should  have  a  molecular  weight  not  exceeding  1500 
Dalton. 
  Other provisions should contain:  
 “The incorporation of the additive into feed should be made via premixtures only”, to 
ensure user safety. 
Since the manganese compounds are not available for control, and valuable information to the user 
of the product can be given only for the final product, the FEEDAP Panel proposes to evaluate the 
possibility of introducing the formulated product in the register of feed additives. 
                                                       
32   Regulation  (EC)  No  183/2005  of  the  European Parliament  and of  the  Council  of  12  January  2005  laying  down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Manganese chelate of amino acids, hydrate, for all species 
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GENERAL REMARKS 
The FEEDAP Panel stresses the need for analytical methods to  quantify the assessed organic 
compounds in feed, independent of the trace element background. 
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APPENDICES 
APPENDIX A 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Manganese (E5)
1 
In the current application authorisation is sought under articles 4(1) and 10(2) for manganese chelate 
of glycine hydrate
2, manganese chelate of amino acids hydrate
2,3, manganous oxide
2,4,5, manganous 
carbonate
2,  manganous  chloride  tetrahydrate
2  and  manganous  sulfate  monohydrate
2,5  under  the 
category/ functional group (3b) "nutritional additives"/"compounds of trace elements", according to 
the classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, authorisation is 
sought for the use of these feed additives for all categories and species. 
According to the Applicants manganese chelate of glycine hydrate is a beige to pink free-flowing 
powder with a minimum content of 20 % total manganese, manganese chelate of amino acids hydrate 
is a off-white to tan marbeled free-flowing powder with a minimum content of 10 % total manganese, 
manganous oxide is a red brown-green powder with a minimum content of 59.5 % total manganese, 
manganous  carbonate  is  a  beige  powder  with  a  minimum  content  of  44  %  total  manganese, 
manganous chloride tetrahydrate is a pink powder with a minimum content of 27 % total manganese 
and manganous sulfate monohydrate is a pink-grey crystalline powder with a minimum content of 31 
% total manganese. These feed additives are intended to be mixed into premixtures, feedingstuffs and 
water*. The Applicants suggested maximum levels ranging from 100 to 150 mg total manganese /kg 
feedingstuffs and from 15 to 75 mg total manganese /L water, similar to limits set in the previous 
regulations [4,5]. 
For  the  characterisation  of  manganous  sulfate  monohydrate  in  the  feed  additive  the  EURL 
recommends the titrimetric method described in the European Pharmacopoeia monograph 1543. 
For  the  quantification  of  “amino  acid”  content  in  the  amino  manganese  chelates (i.e.  manganese 
chelate of glycine hydrate and manganese chelate amino acids hydrate), the Applicant (FAD-2010-
0088) proposed the Community method based on ion exchange chromatography combined with post-
column  ninhydrin  derivatisation  and  photometric  detection  at  570  nm.  The  EURL  considers  the 
Community method suitable for the characterisation of the amino compounds in the frame of official 
control. 
Furthermore,  the  EURL  identified  the  generic  European  Pharmacopoeia  methods  for  the 
"identification reactions of ions and functional groups", such as carbonate, chloride and sulfate in the 
feed additives. Finally, the EURL recommends crystallographic techniques, such as X-Ray diffraction 
for  the  characterisation  of  crystalline  structures  of  manganous  oxide,  manganous  chloride 
tetrahydrate, manganous carbonate and manganous sulfate monohydrate. 
For the quantification of total manganese in the feed additives, premixtures and feedingstuffs the 
Applicants submitted three ring trial validated CEN methods: EN 6869, based on atomic absorption 
spectrometry (AAS), EN 15510, based on inductively coupled plasma atomic emission spectroscopy 
(ICP-AES) and CEN/TS 15621, based on ICP-AES after pressure digestion. Precisions ranging from 2 
to  20 %  were  reported,  together  with limits of  quantification (LOQ)  ranging  from  1  to  5  mg/kg 
feedingstuffs.  Furthermore,  the  EURL  identified  the  comparative  trial  organised  by  the  UK  Food 
                                                       
1  The  full  report  is  available  on  the  EURL  website:  https://ec.europa.eu/jrc/sites/default/files/FinRep-SANCO-
Manganese.pdf 
2  FAD-2010-0088. 
3  FAD-2010-0069. 
4  FAD-2010-0166. 
5  FAD-2010-0235. Manganese chelate of amino acids, hydrate, for all species 
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Standards  Agency,  based  on  the  Community  method  for  the  determination  of  manganese  in 
feedingstuffs, in which precisions ranging from 2.7 to 7.1 % were reported. 
For the quantification of total manganese in water the EURL identified the ring trial validated method 
EN  ISO  11885,  based  on  ICP-AES.  The  following  performance  characteristics  are  reported:  -  a 
relative standard deviation for repeatability (RSDr) ranging from 1.3 to 1.8 %; - a relative standard 
deviation for reproducibility (RSDR) ranging from 4.6 to 6.0 %; and LOQ = 1 μg/L. 
Based on the available performance characteristics the EURL recommends for official control all the 
above mentioned CEN methods together with the Community method to quantify total manganese 
content in the feed additives, premixtures, feedingstuffs and/or water. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
 
 
 
 
 
(*)  for  manganese  chelate  of  glycine  hydrate,  manganous  chloride  tetrahydrate  and  manganous 
sulfate monohydrate (FAD-2010-0088). Manganese chelate of amino acids, hydrate, for all species 
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APPENDIX B 
List of Risk Assessment Reports on manganese and manganese compounds  
Besides the reports cited in the Background section and in the text as references, risk assessments from 
other EU bodies and Institutions have been carried out.  
1.  EC Health and Consumers Scientific Committees Opinions 
Scientific Committee on Food. Opinion on arsenic, barium, fluoride, boron and manganese in natural 
mineral  waters  (Expressed  on  13  December  1996) 
(http://ec.europa.eu/food/fs/sc/oldcomm7/out09_en.html) 
2.  European and other countries Risk Assessment Reports 
Food  Standard  Agency  Risk  Assessment  Manganese 
(http://www.food.gov.uk/multimedia/pdfs/evm_manganese.pdf) 
Health Canada Agency – Human health risk assessment for inhaled manganese  
(http://www.hc-sc.gc.ca/ewh-semt/pubs/air/manganese-eng.php) 
3.  EFSA-ANS Panel Opinions 
Manganese  ascorbate,  manganese  aspartate,  manganese  bisglycinate  and  manganese  pidolate  as 
sources of manganese added for nutritional purposes to food supplements - Scientific Opinion of 
the  Panel  on  Food  Additives  and  Nutrient  Sources  added  to  Food  (ANS). 
(http://www.efsa.europa.eu/en/efsajournal/doc/1114.pdf) 
4.  EFSA-CEF Panel Opinions 
Scientific Report of EFSA on the risk assessment of salts of authorised acids, phenols or alcohols for 
use in food contact materials. (http://www.efsa.europa.eu/en/efsajournal/doc/1364.pdf). 
5.  EFSA-NDA Panel Opinions  
Scientific Report submitted to EFSA - Literature search and review related to specific preparatory 
work  in  the  establishment  of  Dietary  Reference  Values:  Preparation  of  an  evidence  report 
identifying health outcomes upon which Dietary Reference Values could potentially be based for 
chromium, manganese and molybdenum. (http://www.efsa.europa.eu/en/efsajournal/doc/1147.pdf) 
Scientific Opinion on the substantiation of health claims related to manganese and protection of DNA, 
proteins  and  lipids  from  oxidative  damage  (ID  309),  maintenance  of  bone  (ID  310),  energy-
yielding  metabolism  (ID  311),  and  cognitive  function  (ID  340)  pursuant  to  Article  13(1)  of 
Regulation (EC) No 1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1217.pdf) 
 
Scientific  Opinion  on  the  substantiation  of  health  claims  related  to  manganese  and  reduction  of 
tiredness and fatigue (ID 312), contribution to normal formation of connective tissue (ID 404) and 
contribution  to  normal  energy-yielding  metabolism  (ID  405)  pursuant  to  Article  13(1)  of 
Regulation (EC) No 1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1808.pdf) 
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APPENDIX C 
List of authorisations of manganese compounds other than feed additive 
The  following  manganese  compounds  are  authorised  for  use  in  food  (Regulation  (EC)  No 
1170/2009):
6  manganese  ascorbate,  manganese  L -aspartate,  manganese  bisglycinate,  manganese 
carbonate,  manganese  chloride,  manganese  citrate,  manganese  gluconate,  manganese 
glycerophosphate, manganese pidolate and manganese sulphate which may be used in the manufacture 
of food supplements; manganese carbonate, manganese chloride, manganese citrate, manganese 
gluconate,  manganese  glycerophosphate  and  manganese  sulphate  which  may  be    used  in  the 
manufacture of  food supplements and may be added to food. 
The  following  manganese  compounds  can  be  used  for  the  manufacturing  of  dietetic  foods 
(Commission Regulation (EC) No 953/2009):
7 manganese carbonate, manganese chloride, manganese 
citrate, manganese gluconate, manganese glycerophosphate and manganese sulphate. 
The following manganese compounds can be used for the manufacturing of processed cereal -based 
foods  and  baby  foods  for  infants  and  young  children  (Commission  Directive  2006/125/EC):
8 
manganese carbonate, manganese chloride, manganese citrate, manganese  gluconate, manganese 
glycerophosphate and manganese sulphate. 
Regarding pharmacologically active substances and their classification regarding maximum residue 
limits in foodstuffs of animal origin, the following manganese compounds are listed in Table 1 of the 
Annex of Regulation 37/2010
9  as  Allowed  substances,  no  MRL  required:  dimanganese  trioxide, 
manganese  carbonate,  manganese  chloride,  manganese  gluconate,  manganese  glycerophosphate, 
manganese oxide, manganese pidolate, manganese ribonucleate and manganese sulphate. According to 
article 14(7) of Regulation (EC) No 470/2009
10 these compounds are for oral use only.  
The following  manganese compound is listed in Annex of Commission Implementing Regulation 
(EU) No 540/2011
11 as “Active substances approved for use in plant protection products”: manganese 
ethylenebis  (dithiocarbamate,  polymeric)  (Maneb)  and  manganese  ethylenebis  (dithiocarbamate, 
polymeric) complex with zinc salt (Mancozeb). 
The following type of fertilisers for manganese as Fertilisers containing only one micro-nutrient are 
listed in Annex I of Regulation (EC) No 2003/2003
12 of the European Parliament and of the Council: 
(a) manganese salt (chemically obtained product containing a mineral manganese salt (Mn II) as its 
essential ingredient), (b) manganese chelate (water-soluble product obtained by combining manganese 
chemically with a chelating agent),  (c)  manganese oxide (chemically obtained product containing 
manganese oxides as essential ingredients),   (d)  manganese-based fertiliser ( product obtained by 
                                                       
6  Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European 
  Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards 
  the lists of vitamin and minerals and their forms that can be added  to foods, including food supplements. OJ L 314, 
  1.12.2009, p. 36. 
7  Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional 
  purposes in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
8  Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
  young children. OJ L 339, 6.12.2006, p. 16. 
9  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically ac tive substances and their 
  classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1 
10   Regulation (EC) no 470/2009 of the European Parliament and of the Council  of 6 May 2009 laying down Community 
procedures for the establishment of residue limits of pharmacologically  active substances in foodstuffs of animal origin, 
repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of 
the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council OJ L 152, 16.6.2009, p. 11. 
11   Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 
  of the European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1 
12   Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. 
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mixing types (a) and (c)) and (e) manganese-based fertiliser solution (product obtained by dissolving 
types (a) and/or one of the type (b) in water). 
The  following  manganese  compounds  can  be  used  for  cosmetic  purposes  (Regulation  (EC)  No 
1223/2009 of the European Parliament and of the Council):
13 ammonium manganese (3+) diphosphate 
and trimanganese bis (orthophosphate). 
According to the Annex of Regulation (EC) No 432/2012
14 the following health claims can be made 
only for food which is at least a source of manganese as referred to in the claim SOURCE OF [NAME 
OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 
1924/2006
15: manganese contributes to normal energy-yielding metabolism, manganese contributes to 
the maintenance of normal bones, manganese contributes to the normal formation of connective tissue 
and manganese contributes to the protection of cells from oxidative stress. 
 
 
                                                       
13   Regulation  (EC)  No  1223/2009  of  the  European  Parliament  and  of  the  Council  of  30  November  2009  on  cosmetic 
  products. OJ L 342, 22.12.2009, p. 59. 
14   Commission Regulation (EC) No 432/2012 of 16 May 2012  establishing a list of permitted health claims made on foods, 
other than those referring to the reduction of disease risk and to children’s development and health. OJ L 136, 25.05.2012, 
p.1. 
15   Regulation (EC) No 1924/2006 of the  European Parliament and of the council of 20 December 2006  on nutrition and 
health claims made for food. OJ L 404, 30.12.2006, p.9. 
 